Hanna Grauers Wiktorin
Postdoktor vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Angelica Loskog
- E-post:
- hanna.grauers_wiktorin@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 UPPSALA
Publikationer
Senaste publikationer
-
Ingår i ImmunoTargets and Therapy, 2026
- DOI för Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma
- Ladda ner fulltext (pdf) av Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma
-
Ingår i Nature Communications, 2026
- DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
- Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
-
Ingår i Biomarker Research, 2026
- DOI för Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
- Ladda ner fulltext (pdf) av Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
-
Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
Ingår i Human Vaccines & Immunotherapeutics, 2025
- DOI för Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
- Ladda ner fulltext (pdf) av Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
Alla publikationer
Artiklar i tidskrift
-
Ingår i ImmunoTargets and Therapy, 2026
- DOI för Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma
- Ladda ner fulltext (pdf) av Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma
-
Ingår i Nature Communications, 2026
- DOI för LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
- Ladda ner fulltext (pdf) av LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial
-
Ingår i Biomarker Research, 2026
- DOI för Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
- Ladda ner fulltext (pdf) av Reprogramming myeloid cells and restoring T cell fitness in checkpoint inhibitor resistant melanoma patients
-
Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
Ingår i Human Vaccines & Immunotherapeutics, 2025
- DOI för Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines
- Ladda ner fulltext (pdf) av Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines